Formulations of quaternary ammonium neuromuscular blocking agents

Details for Australian Patent Application No. 2006236616 (hide)

Owner Lyotropic Therapeutics, Inc.

Inventors Anderson, David M.

Agent Halford & Co

Pub. Number AU-A-2006236616

PCT Pub. Number WO2006/113462

Priority 60/671,455 15.04.05 US

Filing date 14 April 2006

Wipo publication date 26 October 2006

International Classifications

A61K 31/14 (2006.01) - Quaternary ammonium compounds, e.g. edrophonium, choline

A61K 31/425 (2006.01) - Thiazoles

A61K 31/56 (2006.01) - Compounds containing cyclopenta[a]hydrophenanthrene ring systems

A61K 31/58 (2006.01) - containing heterocyclic rings, e.g. aldosterone, danazol, stanozolol, pancuronium, digitogenin

A61K 31/60 (2006.01) - Salicylic acid

Event Publications

6 December 2007 PCT application entered the National Phase

  PCT publication WO2006/113462 Priority application(s): WO2006/113462

25 March 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006236619-Endoscopic apparatus having an elevator

2006236615-Flashlight charger with an improved contact